Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice

• Main Authors: Maria Stefanatou (Author), Eirini Vasileiadou Kapetanou (Author), Vasilios K. Kimiskidis (Author), Vasileios Papaliagkas (Author), Panagiotis Polychronopoulos (Author), Sofia Markoula (Author), Kleoniki Charisiou (Author), Dimitrios Kazis (Author), Anastasia Verentzioti (Author), Panayiotis Patrikelis (Author), Athanasia Alexoudi (Author), Stylianos Gatzonis (Author)
• Format: Book
• Published: MDPI AG, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Brivaracetam (BRV) is the latest approved antiepileptic drug. The aim of the study was to evaluate the efficacy and tolerability of BRV in everyday clinical practice. In this retrospective, observational, multicenter study, data from epilepsy patients receiving BRV from January 2018 to July 2019 wer...